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Materials and Methods
General
Proton nuclear magnetic resonance ( 1 H NMR) spectra were recorded on Varian-Inova 500 Mhz, Varian-Mercury 300 MHz or Varian-VNMRS 300 MHz spectrometers. Chemical shifts (δ) were reported in parts per million (ppm) relative to tetramethylsilane, and the coupling constants (J) were reported in Hz.
1 H NMR splitting patterns are designated as singlet (s), doublet (d), triplet (t), quartet (q) or pentuplet (p). All first-order splitting patterns were assigned based on the appearance of the multiplet. Splitting patterns that could not be easily interpreted are designated as multiplet (m) or broad (br). Carbon nuclear magnetic resonance ( 13 C NMR) spectra were recorded on Varian-Inova 500 MHz, Varian-Mercury 300 MHz or Varian-VNMRS 300 MHz spectrometers. Carbon resonances were assigned using distortionless enhancement by polarization transfer (DEPT) spectra obtained with phase angles of 135°.
Electrospray (ESI) mass spectra were recorded on a Bruker BIOTOF II mass spectrometer. FT-IR measurements were made on a JASCO FT/IR-400 and PerkinElmer FT-IR Spectrum Two spectrophotometers using 5-10 mM in CHCl3 and placed in a CaF2 solution IR cell.
►
H NMR Assignments of Cyclic Peptides (CPs)
. The signals of the 1 H NMR spectra of the peptides in CDCl3 were identified from the corresponding double-quantum-filled 2D COSY (2QF-COSY), TOCSY and/or NOESY and ROESY spectra acquired at concentration and temperature indicated. Mixing times (~250 ms or 400 ms) were not optimized. Spectra were typically acquired using Bruker standard pulse sequences on 300 and 500 MHz apparatuses, and were referenced relative to residual proton resonances in CDCl3 (at 7.26 ppm). 
Amino acid and peptide synthesis:
BocMe N-δ-Ach-OMe: A solution of Boc-δ-Ach-OH (1.0 g, 4.11 mmol) in dry DMF (30 mL) was treated with NaH (490 mg, 60% in mineral oil, 12.3 mmol) and stirred at 0 °C for 30 min. Then, iodomethane (780 µL, 12.6 mmol) was added and the resulting mixture was stirred at rt for 24 h. After quenching with water, the mixture was washed with diethyl ether, and the organic layer was dried over Na2SO4 anhydrous, filtered and concentrated under reduced pressure providing a yellow oil that was purified by flash chromatography (20% EtOAc in hexanes) to obtaining 1.07 g of Boc- 
Boc-
Me
N-δ-Ach-OH: A solution of Boc-
Me N-δ-Ach-OMe (600 mg, 2.21 mmol) in MeOH/H2O (3:1, 30 mL) was treated with LiOH (258 mg, 11.1 mmol) and stirred at rt for 2 h. Then, the MeOH was concentrated under reduced pressure and the aqueous solution was acidified to pH 3 with an aqueous solution of HCl (10%). The resulting mixture was extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers were dried over Na2SO4 anhydrous, filtered and concentrated to afford the wished product as white solid. [98%, Rf = 0.4 (5% MeOH in CH2Cl2)]. Boc-δ-Ach-OFm: A solution of Boc-δ-Ach-OH (1.0 g, 4.11 mmol) in dry CH2Cl2 (40 mL) was successively treated with EDC·HCl (1.18 g, 6.17 mmol), HOBt (835 mg, 6.17 mmol), 9-fluorenylmethanol (966 mg, 4.9 mmol) and DMAP (755 mg, 6.17 mmol). The resulting mixture was stirred at rt for 3 h, then poured into a separatory funnel and the organic layer was washed with aqueous solutions of HCl (5%, 3 x 20 mL) and NaHCO3 (dil. sat., 3 x 20 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated under reduced pressure, providing a yellow residue that was purified by flash chromatography (25% EtOAc in hexanes) to give 450 mg of the Boc-δ-Ach-OFm as white solid [82%, Rf = 0.7 (50% AcOEt in hexanes)]. Boc-δ-Ach-OAll: A solution of Boc-δ-Ach-OH (1.0 g, 4.11 mmol) in dry CH2Cl2 (40 mL) was treated with EDC·HCl (1.58 g, 8.20 mmol), AllOH (800 µL, 12.3 mmol) and DMAP (100 mg, 0.820 mmol). The resulting mixture was stirred at rt for 2 h, then poured into a separatory funnel and the organic layer was washed with aqueous solutions of HCl (5%, 3 x 20 mL) and NaHCO3 (dil. sat., 3 x 20 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated under reduced pressure, providing a yellow residue that was purified by flash chromatography (0.5% MeOH in CH2Cl2) to obtain 1.04 g of the Boc-δ-Ach-OAll as white solid [87%, Rf = 0.8 (5% MeOH in CH2Cl2)]. Fmoc-L-Lys(Boc)-δ-Ach-OAll (Dp2): A solution of Boc-δ-Ach-OAll (450 mg, 1.58 mmol) in a mixture of TFA/CH2Cl2 (1:1, 10 mL) was stirred at rt for 15 min and then the solvent was removed under reduced pressure. The residue was dried under high vacuum for 3 h. The resulting TFA salt was dissolved in dry CH2Cl2 (9 mL) and then DIEA (1.8 mL, 10.6 mmol), Fmoc-L-Lys(Boc)-OH (827 mg, 1.80 mmol) and N-HATU (839 mg, 2.20 mmol) were successively added. The resulting solution was stirred at rt for 40 min and then poured into a separatory funnel. The solution was washed with aqueous solutions of HCl (5%, 3 x 10 mL) and NaHCO3 (dil. sat., 3 x 10 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated under reduced pressure. The resulting yellow oil was purified by flash chromatography (1% MeOH in CH2Cl2) to give 939 mg of Dp2 as white solid. [93.5%, Rf = 0.40 (5% MeOH in CH2Cl2)]. (1:4, 2 mL) and was stirred at rt for 30 min. The resulting mixture was poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 10 mL), dried over Na2SO4 anhydrous, filtered and concentrated to give Tp2a as white foam, which was used without further purification.
A solution of tetrapeptide Tp1a (57 mg, 0.069 mmol) in a mixture of TFA/PhSiH3/CH2Cl2 (25:10:65, 2 mL) was stirred at rt for 10 min and then the solvent was removed under reduced pressure. The resulting residue was dried under high vacuum for 3 h. This residue was dissolved in dry CH2Cl2 (1 mL), treated with DIEA (25 µL, 0.12 mmol) and a solution of previously prepared Tp2a, DIEA (40 µL, 0.24 mmol) and N-HBTU (28 mg, 0.073 mmol) in dry CH2Cl2 (1.5 mL) was added. The resulting reaction mixture was stirred at rt for 60 min. Then, the solution was poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 5 mL) and NaHCO3 (dil. sat., 3 x 5 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated. The resulting yellow oil was purified by flash chromatography (2-5% MeOH in CH2Cl2) to give 50 mg of The linear octapeptide Op1a (175 mg, 0.129 mmol) was dissolved in a mixture piperidine/CH2Cl2 (1:4, 4 mL) and the solution was stirred at rt for 30 min. The mixture was poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 10 mL), dried over Na2SO4 anhydrous, filtered and concentrated giving octapeptide Op3a, which was used without further purification.
Op3a was dissolved in mixture of TFA/PhSiH3/CH2Cl2 (25:10:65, 3 mL) and stirred at rt for 10 min. Then, the solvent was removed under reduced pressure and the resulting solid was dried under high vacuum for 3 h, providing the octapeptide Op4b. This compound was dissolved in dry CH2Cl2 (130 mL) under Ar and then sequentially treated with DIEA (135 µL, 0.774 mmol) and N-TBTU (46 mg, 0.142 mmol). The reaction mixture was stirred at rt for 12 h and then the solution was concentrated to dryness. The residue was dissolved in CH2Cl2 (10-15 mL) and washed with aqueous solutions of HCl (5%, 3 x 5 mL), dried over Na2SO4 anhydrous, filtered and concentrated. The resulting yellow oil was purified by flash chromatography (2-6% MeOH in CH2Cl2) to give 57 mg of CP4 as white solid. [42%, Rf = 0.22 (5% MeOH in CH2Cl2)]. 
Boc-[(D-Tyr(Me)-
The tetrapeptide Tp1a (27.1 mg, 0.033 mmol) was dissolved in a mixture of TFA/PhSiH3/CH2Cl2 (25:10:65, 2 mL) and stirred at rt for 10 min. Then, the solvent was removed under reduced pressure and the resulting solid was dried under high vacuum for 3 h to obtain Tp3a, which was used without further purification.
A solution of Op1a (45 mg, 0.035 mmol) in a mixture of piperidine/CH2Cl2 (1:4, 2 mL) was stirred at rt for 30 min. Then, the reaction mixture was poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 10 mL), dried over Na2SO4 anhydrous, filtered and concentrated to obtain octapeptide Op3a as white foam, which was used without any further purification.
A solution of tetrapeptide Tp3a in dry CH2Cl2 (850 µL) was treated with DIEA (12 µL 0.07 mmol) and then a solution of previously prepared Op3a, DIEA (24 µL, 0.14 mmol) and N-HATU (15 mg, 0.039 mmol) in dry CH2Cl2 (1 mL) was added. The resulting reaction mixture was stirred at rt for 2 h, and then poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 3 mL) and NaHCO3 (dil. sat., 3 x 3 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated. The (1:4, 2 mL) was stirred at rt for 30 min and then poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 5 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated to obtain the C-terminus unprotected dodecapeptide Dd2. Then, this peptide Dd2 was dissolved in a mixture of TFA/PhSiH3/CH2Cl2 (25:10:65, 2 mL) and stirred at rt for 5 min. The solvent was removed under reduced pressure and the resulting residue was dried under high vacuum for 3 h to provide the dodecapeptide Dd3, which was used without further purification.
The unprotected dodecapeptide Dd3 was dissolved in dry CH2Cl2 (16 mL) under Ar and treated with DIEA (17 µL, 0.096 mmol) and N-TBTU (5.6 mg, 0.018 mmol). The reaction mixture was stirred at rt for 12 h and then poured into a separation funnel and washed with aqueous solutions of HCl (5%, 3 x 5 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated. The resulting yellow oil was purified by flash chromatography (2%-10% MeOH in CH2Cl2) obtaining 9 mg of CP5 as white solid. [30%, Rf = 0.45 (10% MeOH in CH2Cl2)]. A solution of octapeptide Op1b (50 mg, 0.041 mmol) in a mixture of TFA/PhSiH3/CH2Cl2 (25:10:65, 2 mL) was stirred at rt for 5 min. The solvent was removed under reduced pressure and the resulting solid was dried under high vacuum for 3 h to give octapeptide Op3b, which was used without further purification.
A solution of octapeptide Op1b (50 mg, 0.041 mmol) in a mixture of piperidine/CH2Cl2 (1:4, 2 mL) was stirred at rt for 30 min. The reaction mixture was poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 5 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated to provide the Cterminus unprotected octapeptide Op2b as white foam, which was used without further purification.
A solution of the previously prepared Op3b in dry CH2Cl2 (1.0 mL) was treated with DIEA (14 µL 0.082 mmol) and then a solution of Op2b, DIEA (28 µL, 0.164 mmol) and N-HBTU (19 mg, 0.049 mmol) in dry CH2Cl2 (1.0 mL) was added. The resulting reaction mixture was stirred at rt for 2 h and then poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 5 mL) and NaHCO3 (dil. sat., 3 x 3 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated. The resulting yellow oil was purified by flash chromatography (3- (1:4, 1 mL) was stirred at rt for 30 min. Then, the resulting solution was poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 5 mL), dried over Na2SO4 anhydrous, filtered and concentrated to provide Hd2, which was used without further purification.
A solution of hexadecapeptide Hd2 in a mixture of TFA/PhSiH3/CH2Cl2 (25:10:65, 1 mL) was stirred at rt for 10 min. Then, the solvent was removed under reduced pressure and the residue was dried under high vacuum for 3 h to obtain the unprotected peptide Hd3, which was used without further purification.
A solution of the peptide Hd3 in dry CH2Cl2 (23 mL) was treated with DIEA (24 µL, 0.14 mmol) and N-HATU (11 mg, 0.028 mmol). The reaction mixture was stirred at rt for 12 h and then poured into a separatory funnel and washed with aqueous solutions of HCl (5%, 3 x 10 mL). The organic layer was dried over Na2SO4 anhydrous, filtered and concentrated. The yellow residue was purified by flash chromatography (4-9% MeOH in CH2Cl2) followed by HPLC purification (1:1, 5 mL) was stirred at rt for 15 min. After this time, the solvent was removed under reduced pressure and the resulting residue was dried under high vacuum for 4h to give Dp3a as white solid, which was used without further purification.
2-CTC-resin (300 mg, 0.150 mmol) was swelled in dry CH2Cl2 (3 mL) for 2 h and then washed with dry CH2Cl2 (3 x 2 mL, 2 min). A solution of Fmoc-L-Lys-δ-Ach-OAll (200 mg, 0.375 mmol) and DIEA (128 µl, 0.75 mmol) in CH2Cl2 (2 mL) was stirred at rt for 5 min. The mixture was added over a peptide synthesis vessel that contains the previously swelled 2-CTC-resin (300 mg, 0.150 mmol). The corresponding suspension was mechanically stirred for 2 h and then filtered and washed with dry CH2Cl2 (3 x 2 ml, 2 min) and Et2O (3 x 2 mL, 2 min). The loading of the resulting resin (0.324 mmol/g) was calculated using Fmoc test. 3 Finally, the resin was washed with a mixture of CH2Cl2/MeOH/DIEA (8.5:1:0.5, 2 x 2 ml, 10 min), CH2Cl2 (3 x 2 mL, 2 min), DMF (3 x 2 mL, 2 min) and finally CH2Cl2 (3 x 2 ml, 2 min) to afford the desired Fmoc-L-Lys(CTC-resin)-δ-Ach-OAll. Solid phase synthesis: CP7 was synthesized by manual Fmoc solid-phase peptide synthesis from Fmoc-L-Lys(CTC-resin)-δ-Ach-OAll, following the standard protocol.
Thioflavin T fluorescence emission assays:
Fluorescence emission experiments were carried out using a Cary Eclipse Fluorescence Spectrophotometer (Agilent) with an excitation wavelength of 420 nm and recording the spectra between 440-650 nm with 5 nm slit. Emission spectra were measured adding different volumes of 2 mM stock solution of CP7 in Mili-Q water (pH 3.3) or TRIS buffer at pH 8.1 over a 20 µM solution of ThT (Thioflavin T, Acros Organics).
Solubilization of C60 in aqueous media:
C60 fullerene (1 mg, Sigma Aldrich) was suspended in a 1 mM solution of CP7 in Mili-Q water at basic pH 8.1. pH was adjusted by addition of small aliquots of NaOH (0.1 M in Mili-Q water). The suspension was sonicated for 40 min in a Branson 2800 Ultrasonic Cleanear. Then, 3 cycles of 5 min in a Branson 450 SSE-1 tip horn ultrasonicator (20 cycles per min, 20% power) and another 40 min in the Branson 2800 Ultrasonic Cleaner. Finally, the suspension was centrifuged at 7500 rpm for 10 min and the supernatant of CP7+C60 was carefully decanted. UV/vis spectroscopy experiments were carried out to estimate the amount of dissolved fullerene. The UV/vis spectra were recorded in a Biochrom Libra S60 Double Beam UV/vis spectrophotometer between 200 nm and 700 nm.
Atomic Force Microscopy (AFM):
AFM measurements were conducted in ambient atmosphere at room temperature using a XE-100 instrument (Park Systems Corporation) and AFM-Nanoscope V (Bruker) in non-contact mode. The high-resonance non-contact AFM cantilever (ACTA probe, ν = 330 kHz). For AFM CP7 imaging, 20 μL of 2 mM solution in TRIS buffer at pH 8.1 were dropped onto freshly exfoliated mica disc (Ted Pella Inc. PELCO® Mica Discs, 9.9 mm Diameter) and after 1 min mica was dried under nitrogen flow. For AFM CP7+C60 imaging, 20 µL of sample described above were dropped onto freshly exfoliated mica disc (Ted Pella Inc. PELCO® Mica Discs, 9.9 mm Diameter) and after 1 min mica was thoroughly washed with Mili-Q water and dried under nitrogen flow.
Scanning Transmission Electron Microscopy (STEM):
CP7+C60 sample were drop casted in commercial microscopy grids (carbon type B film on 300 mesh cooper grid). After 10 min the sample excess was removed by placing the grid onto a filter paper and left to dry at room temperature overnight. The sample was stained with a 2% uranyl acetate solution by depositing a droplet onto the grid. The excess was removed with filer paper and left to dry at room temperature for 1 h. Micrographs were recorded with Zeiss Fesem Ultra Plus with EDX operating at 0.2 kV.
